Zavesca and acquired claw toe Patient Reports February 11, 2012



Zavesca Side Effects Report #5319705-3
Zavesca side effect was reported by a Physician from FRANCE on Apr 20, 2007. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, chronic inflammatory demyelinating polyradiculoneuropathy, condition aggravated, diarrhoea, epilepsy What is  epilepsy, flatulence, guillain-barre syndrome What is  guillain-barre syndrome, joint sprain. Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #5122624-9
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Sept 21, 2006. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, chitotriosidase decreased, condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy What is  epilepsy, flatulence, guillain-barre syndrome What is  guillain-barre syndrome, joint sprain. Zavesca dosage: 100 MG, TID, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #4824677-1
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Oct 17, 2005. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy What is  epilepsy, flatulence, guillain-barre syndrome What is  guillain-barre syndrome. Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Zavesca